The paper
Hoofnagle JH
National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda · 19 Sep 2026
More on Chronic kidney disease
SGLT2 inhibitors raise genital but not urinary infection risk
Clinical Pharmacology and Therapeutics · 4 Oct 2026
Semaglutide curbs kidney vascular resistance and fibrosis
Nature Medicine · 4 Oct 2026
SGLT2 inhibitors match GLP-1 drugs for overall kidney outcomes
Clinical Journal of the American Society of Nephrology · 4 Oct 2026
Low-carb telemedicine links to fewer cardiovascular events
Cardiology and Therapy · 4 Oct 2026